FEATURE ARTICLES
Pharmaceutical innovation is making drug manufacturing more complex—and placing new demands on facility design. Accommodating today’s processes is no longer enough. Facilities must also be able to change. Modular design offers a way to build that adaptability into the facility itself.
- Why Early Evaluation Of Process Parameters Matters In OSD Scale-Up
- Navigating Outsourced Pharmaceutical Testing Through Today's Geopolitical Uncertainty
- Is Your Supply Chain Ready For The End Of Class VI?
- Printing A New Path To The Brain: 3D Buccal Nanofilms For CNS Lymphoma
- Capturing Tablet Disintegration for Improved OSD Development
- Beyond API Sourcing: Avoiding Supply Disruptions For Small Molecule Drugs
- Why We Need Pharmaceutical Engineering Project Management As A Distinct Discipline
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-1173354781 protein degradation]( "Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging")
Accelerating Small Molecule Protein Degrader Development Using High-Content ImagingHigh‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.
-
Enhancing mAb Production: Advanced Downstream Purification Strategies9/1/2026
Explore how process optimization can address downstream mAb manufacturing bottlenecks, reduce labor and consumable costs, and support more efficient production without compromising performance.
-
Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)5/6/2026
Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.
-
Extraction And Chemical Characterization Pitfalls In Complex Medical Devices8/20/2026
Standard extraction protocols routinely fail tissue-derived products, hydrogels, absorbables, and silicone implants. Learn the material-specific study design strategies that prevent regulatory rejection and repeat work.
-
Reducing Costs & Risks: A Pharma Guide To FTZ Subzones For U.S. Drug Manufacturing2/11/2025
Utilized wisely, FTZs and subzones can be tools for cost savings and can enable pharma companies to leverage the benefits of American manufacturing.
-
Is Your Water Undermining Your Results?10/15/2026
Water is often chosen by availability rather than application. Defining it as a controlled process parameter targets a variability source that routinely escapes root cause analysis.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Validation Provider Shortens The Path To Equipment Qualification
- Manufacturing Glycosylated Erythropoietin Without 𝛼1,3-Fucosylation
- Removing Bacteria In Biopharmaceutical Formulation And Filling Systems
- Native SEC-MALS Characterization Using A Chromatography Data System
- Advantages Of Spray-Dried Mannitol In Roll Compaction
NEWSLETTER ARCHIVE
- 10.28.26 -- OPCU: Key Strategies For Advancing ADCs Toward Commercialization
- 10.28.26 -- Accelerating Advanced Therapies: From Development To Manufacturing
- 10.28.26 -- Find Your Next Pharma Processing Solution
- 10.27.26 -- Reduce Bioprocessing Supply Risk With Manufacturing Closer To You
- 10.27.26 -- Your 7 Decisions To Make Before MES Configuration
- Designing Pharma Facilities For Change, Not Just Capacity
- Why Early Evaluation Of Process Parameters Matters In OSD Scale-Up
- Printing A New Path To The Brain: 3D Buccal Nanofilms For CNS Lymphoma
- Capturing Tablet Disintegration for Improved OSD Development
- Why CMC Tech Transfer Should Begin With The End In Mind
NEW FOR OUR READERS
INDUSTRY NEWS
-
![white coupon banner, great topic-GettyImages-2271702407]( "Let Your Voice Help Shape Pharma Manufacturing")
Let Your Voice Help Shape Pharma ManufacturingPharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
![rating service, satisfaction-GettyImages-2221603596]( "ISPE Announces 2026 FOYA Winners")
ISPE Announces 2026 FOYA WinnersThese awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
EDITORIAL COLLECTIONS
Our curated Editorial Collections bring expert insights together in one place, offering practical perspectives and actionable guidance to help you navigate complex decisions and improve performance.
More Editorial CollectionsSUPPLIER NEWS
-
Meissner Hosts Ribbon Cutting Ceremony For X-Ray Irradiation Services And Breaks Ground On Phase 2 Of Its Athens, Georgia, U.S.A. Campus10/23/2026
Meissner Corporation, a leading manufacturer of advanced microfiltration and therapeutic manufacturing systems for biopharmaceutical production of life-saving and life enhancing medicines, celebrated a double milestone in Athens-Clarke County: the ribbon cutting for its new X-ray irradiation services facility and the groundbreaking for Phase 2 of its Athens, Georgia, U.S.A., manufacturing campus.
-
Global Pharma Manufacturing Community Meets In Berlin For PHARMAP 202710/22/2026
Senior pharma professionals gather in Berlin on 19-20 April for the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2027 to address the growing disconnect between investment and outcomes. The closed-door format, supported by Host Sponsor Bayer AG, fosters direct dialogue between pharmaceutical companies, contract manufacturing organisations and service providers, creating space for ongoing discussions that move beyond theory and deliver actionable solutions.
-
LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical And GLP Bioanalytical Services10/22/2026
LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and drug development services, today announced it has acquired Sannova Analytical, a contract research laboratory headquartered in Somerset, N.J. The acquisition expands LGM Pharma’s analytical testing services business by adding Good Laboratory Practice (GLP) bioanalysis, including peptide and oligonucleotide testing, and by bringing genotoxic and nitrosamine impurity testing, extractables and leachables evaluations, and additional elemental impurities testing to LGM Pharma’s existing cGMP analytical services. Sannova will continue to operate under its own name as Sannova Analytical, led by its current management team.
-
MVIC And Upperton Pharma Solutions Announce Strategic Collaboration10/20/2026
MVIC (Medicon Valley Inhalation Consortium) and Upperton Pharma Solutions today announced a strategic collaboration designed to provide pharmaceutical and biotech companies with a seamless, end-to-end solution spanning early discovery, formulation development, preclinical support, and clinical trial manufacturing.
